How much does Humata Health cost?

Enterprise sales led; no public pricing.

Back to vendors

Humata Health

Q: Who is Humata Health for?

health systems, revenue cycle teams, payers

Visit site

Healthcare agentindependentVerified 2026-07-22

Touchless prior authorization AI for providers and payers, built on AI policy matching, automated statusing, and gold carding across medical procedures and specialty drugs, carrying forward Olive AI's prior authorization business.

Humata Health automates prior authorization across medical procedures and specialty drugs for both providers and payers. The platform is built on AI policy matching against payer requirements, automated statusing of pending requests, and gold carding programs, with a stated aim of roughly 90 percent touchless authorizations. Its roots are in Olive AI's prior authorization business, and it raised about $25 million in 2024 to carry that work forward. Spanning both sides of the transaction, it lands most naturally with enterprise revenue cycle teams and health systems applying it across a wide procedure mix.

Vendor details

Canonical URL

https://www.humatahealth.com

Funding status

~$25M raised 2024; Olive AI prior authorization lineage

Company status

independent

Use cases & customers

Primary use cases

touchless prior authorization submissionautomated authorization statusinggold cardingspecialty drug authorizations

Target customers

health systemsrevenue cycle teamspayers

Deployment options

SaaS

Integrations

Provider and payer side connectivity for authorization submission and statusing; details not publicly documented.

Sources & related URLs

Research sources

https://www.honeyhealth.ai/articles/10-best-ai-surgical-prior-authorization-tools-2026

Capability coverage

5.0 / 14 capabilities · 36%

Integrations & Tool CallingProvider and payer side connectivity for submission and statusing; integration catalog not publicly documented, third party PA analysis 2026-07-22	Partial
Workflow OrchestrationAutomates prior authorization end to end across submission, statusing, and gold carding with a roughly 90 percent touchless target, third party PA analysis 2026-07-22	Full
Knowledge Grounding & RAGAI policy matching against payer specific requirements is the platform's core documented capability, third party PA analysis 2026-07-22	Full
Human Oversight & GuardrailsA 90 percent touchless target implies exception routing to humans, but no formal oversight framework is documented, third party PA analysis 2026-07-22	Partial
Security, Identity & GovernanceNo security certifications or identity governance documented in retrieved materials, 2026-07-22	Unable to verify
Observability & AuditabilityAutomated statusing provides authorization visibility; no audit trail or reporting console documented, third party PA analysis 2026-07-22	Partial
Memory & State PersistenceNo documented persistent agent memory capability, retrieved materials 2026-07-22	Unable to verify
Deployment & Data ResidencyEnterprise SaaS; no self host or residency options documented, retrieved materials 2026-07-22	Partial
Prebuilt Agents, Templates & PacksProvider and payer products spanning procedures and specialty drugs plus gold carding programs; no broader agent library documented, third party PA analysis 2026-07-22	Partial
Triggers & Channel CoverageAutomated statusing monitors pending authorizations, but the trigger surface is not documented as first class, third party PA analysis 2026-07-22	Partial
Model Flexibility & RoutingNo customer facing model choice or routing documented, retrieved materials 2026-07-22	Unable to verify
APIs, SDKs & MCP ExtensibilityNo public developer API, SDK, or MCP surface documented, retrieved materials 2026-07-22	Unable to verify
Testing, Debugging & OptimizationNo customer facing testing or evaluation tooling documented, retrieved materials 2026-07-22	Unable to verify
Browser & Computer UseOperates through authorization workflows and system connectivity, not browser or computer interface control, retrieved materials 2026-07-22	Unable to verify

Pricing

Contact sales

Contact onlyHigh variable cost

What is public

No public pricing. Third party analysis describes enterprise revenue cycle deployments across wide procedure mixes.

Variable cost rationale

Enterprise pricing scoped to authorization volume and procedure mix across provider and payer deployments; no public rates.

Sales call required

Yes — required for paid access

Free / trial

None public

Verified 2026-07-22

Data confidence: medium